Search

91 results
  1. Jean-Philippe Coton, fondateur de Histalim ©DR

    Histalim, developing personalized medicine

    Histalim develops biomarkers that show a tumor’s immune profile, providing a diagnostic tool that is unique in Europe. The Montpellier company, which joined the Cerba Healthcare group in 2018, is f...

  2. Roland Sicard et Clément Sicard - La Valériane©David Crespin

    Meeting our success stories / Interview with Roland Sicard, CEO of La Valériane

    “The key to success is to combine technology and human factors”

  3. Dinah Weissmann, directrice adjointe de Sys2diag et directrice générale déléguée d’Alcediag

    Sys2Diag diagnoses psychiatric illnesses

    Alcediag and CNRS join forces to create Sys2Diag Specialized in medical diagnostics and psychiatric illnesses, the laboratory recently created a blood test to diagnose depression and suicidal behav...

  4. The Metropolitan Innovation Pact

  5. La santé, cœur battant de la Métropole de Montpellier

    Health, the beating heart of the Montpellier metropolitan area

    A land of achievements, the Montpellier Méditerranée Métropole area has earned international recognition in the health field, joining teaching, research, innovation, and quality of life throughout ...

  6. Kyomed Innov accompagne le développement des solutions de santé de demain

    KYomed INNOV, working to develop tomorrow’s health solutions

    Founded in 2014 to study innovative health devices, KYomed INNOV has been designing solutions since 2018. The dynamic company, based in Biopôle Euromédecine, is coordinating a health project as par...

  7. Health / Independent Living Cluster

  8. #HealthTech: Health in our genes

  9. Montpellier France Health Hub

    Montpellier France Health Hub

    Health-related activities are a major asset for the Montpellier Méditerranée Métropole area’s attractiveness and dynamics as an excellence sector. Innovation and research stakeholders unite under a...

  10. Francooise Cailler Surgimab

    2018, a pivotal year for SurgiMAb

    The Montpellier biotech company SurgiMAb is preparing to launch Phase III testing of its fluorescent SGM-101 compound on 300 patients with gastrointestinal cancers. A critical step before market re...

Pages